保留乳头乳房切除术后胸肌前与胸肌下乳房再造的并发症与结局比较
该回顾性研究纳入2013至2023年693例保留乳头乳房切除术后两阶段假体乳房再造患者,比较胸肌前(345例)与胸肌下(348例)平面。胸肌前组手术部位感染和血清肿发生率更高,但BREAST-Q胸部身体舒适度评分更优。作者认为选择假体平面时需权衡感染与血清肿风险增加与患者报告结局改善。
要点
- 胸肌前组手术部位感染率10%,胸肌下组5.7%(P=0.03)。
- 胸肌前组血清肿发生率15%,胸肌下组6.6%(P<0.001)。
- 胸肌前组BREAST-Q胸部身体舒适度评分显著更高(β=3.4,P=0.01)。
核心结论
- 保留乳头乳房切除术后胸肌前再造相比胸肌下假体置入,手术部位感染和血清肿发生率更高,但胸部身体舒适度改善。
- 作者认为决定保留乳头乳房切除术后假体平面时,应将感染和血清肿风险增加与患者报告结局改善进行权衡。
研究设计与样本
- 回顾性综述,纳入2013至2023年接受保留乳头乳房切除术后两阶段假体乳房再造的患者。
- 共693例患者,其中345例行胸肌前再造,348例行胸肌下再造。
- 按胸肌前或胸肌下置入分组,评估术后并发症和BREAST-Q评分。
主要发现
- 手术部位感染发生率胸肌前组10%,胸肌下组5.7%(P=0.03)。
- 血清肿发生率胸肌前组15%,胸肌下组6.6%(P<0.001)。
- 多变量分析显示,胸肌前组发生手术部位感染的比值比为1.87(P=0.04),发生血清肿的比值比为2.52(P<0.001)。
- 胸肌前再造与胸肌下假体置入相比,BREAST-Q胸部身体舒适度评分显著更高(β=3.4,P=0.01)。
关键数值与推荐
- 手术部位感染:胸肌前组10% vs 胸肌下组5.7%(P=0.03)。
- 血清肿:胸肌前组15% vs 胸肌下组6.6%(P<0.001)。
- 多变量分析:手术部位感染OR=1.87(P=0.04),血清肿OR=2.52(P<0.001),均为胸肌前组对比胸肌下组。
- BREAST-Q胸部身体舒适度评分:胸肌前组对比胸肌下组β=3.4(P=0.01)。
临床怎么用
- 作者认为决定保留乳头乳房切除术后假体平面时,应将感染和血清肿风险增加与患者报告结局改善进行权衡。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Preprectoral breast reconstruction and nipple-sparing mastectomy (NSM) have both risen in popularity because of advances in reconstructive techniques. However, it is unknown whether exposed lactiferous ducts in an NSM may increase the risk for infection after prepectoral implant-based breast reconstruction. The authors aimed to assess complication rates and BREAST-Q physical well-being of the chest scores in patients who underwent NSM and implant-based breast reconstruction in a prepectoral versus submuscular plane. METHODS: A retrospective review was performed of patients who underwent NSM with 2-stage implant-based reconstruction from 2013 to 2023. Patients were grouped by prepectoral or submuscular placement. Postoperative complications and BREAST-Q scores were assessed after surgery. RESULTS: A total of 693 patients were included: 345 underwent prepectoral and 348 underwent submuscular reconstruction. Surgical-site infection occurred in 10% of prepectoral patients and 5.7% of submuscular patients ( P = 0.03). Seroma occurred in 15% of prepectoral patients and 6.6% of submuscular patients ( P < 0.001). Multivariable analysis showed that prepectoral patients had significantly increased odds of developing surgical-site infection and seroma compared with submuscular patients (OR, 1.87; P = 0.04 and OR, 2.52; P < 0.001, respectively). However, prepectoral reconstruction was associated with significantly higher BREAST-Q physical well-being of the chest scores as compared with submuscular implant placement (β, 3.4; P = 0.01). CONCLUSIONS: Prepectoral reconstruction following NSM is associated with higher rates of surgical-site infection and seroma but improved physical well-being of the chest compared with submuscular implant placement following NSM. An increased risk of infection and seroma should be weighed against improved patient-reported outcomes when deciding on implant plane placement after NSM. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III.
引用
- Wang J, Shammas RL, Montes-Smith E, et al. Prepectoral versus Submuscular Breast Reconstruction after Nipple-Sparing Mastectomy: Complications and Outcomes. Plast Reconstr Surg. 2025. PMID: 40100118. doi:10.1097/PRS.0000000000012096
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。